📰 Claudio Nessi News
Claudio Nessi News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Claudio Nessi. Real-time updates on events, politics, business and more.
January 24, 2024
PRESS RELEASEREGULATED INFORMATION 24 January 2024, 06:00 pm CET Ghent, Belgium – 24 January 2024 – Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana Medical"), a pioneer in the treatment of fluid overload in liver disease, heart failure and cancer, announces today that it received transparency notifications from the shareholders listed below, notifying the number of voting rights attached to shares mentioned next to their respective names...
February 9, 2023
PRESS RELEASEREGULATED INFORMATION09 February 2023, 07:00 am CEST Ghent, Belgium - 09 February 2023 - Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana Medical")
February 9, 2023
PRESS RELEASE Regulated information 09 February 2023, 07:00 am CEST Ghent, Belgium - 09 February 2023 - Sequana Medical NV , a pioneer in the... | February 9, 2023
January 10, 2023
EQS-News: Andera Partners / Key word(s): Financing Andera Partners invests in SoniVie, a medtech company developing a promising device for the treatment of hypertension 10.01.2023 / 08:30 CET/CEST The issuer is solely responsible for the content of this announcement. Andera Partners invests in S...
January 9, 2023
/PRNewswire/ -- SoniVie Ltd. ("SoniVie" or the "Company"), a medical device company developing a proprietary solution to treat hypertension, announced today...
April 13, 2022
Proceeds Support Advancement of the M-gager Platform Technology and Lead Product Candidate CDR404, a First Antibody Fragment-based Dual MAGE-A4 T Cell Engager, and Other Discovery ProgramsZÜRICH, Switzerland
April 13, 2022
CDR-Life is a Swiss Biotech company at the forefront of a new class of highly tumor-specific immuno-oncology therapeutics. CDR-Life leverages the unique expertise and track record of its founders
April 13, 2022
Investegate announcements from CDR-Life AG, CDR-Life Announces $76 Million Raised in Series A Funding
March 18, 2022
Investegate announcements from Sequana Medical NV, Transparency Notifications from Shareholders
March 18, 2022
PRESS RELEASEREGULATED INFORMATION 18 March 2022, 6 p.m. CET Ghent, Belgium - 18 March 2022 - Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana Medical")